What is the most likely diagnosis for a patient presenting with persistent low mood, anhedonia, irritability, anger outbursts, and anxiety?

Major Depressive Disorder with Comorbid Anxiety

The most likely diagnosis for a patient presenting with persistent low mood, anhedonia, irritability, anger outbursts, and anxiety is Major Depressive Disorder (MDD) with comorbid anxiety symptoms or disorder.

Diagnostic Criteria and Rationale

The symptom constellation you describe meets criteria for MDD, which requires at least 2 weeks of either depressed mood OR anhedonia, plus at least 5 total symptoms including significant distress or functional impairment 1. Your patient presents with both core symptoms (low mood and anhedonia), making the diagnosis straightforward.

Critically, irritability is a highly prevalent but underrecognized feature of adult MDD. While not a diagnostic criterion in DSM-IV/5 for adults (though it is for children/adolescents), irritability occurs in approximately 50-54% of adults with MDD 2, 3. The presence of irritability and anger in MDD signals:

• More severe and chronic depressive illness
• Higher rates of comorbid anxiety disorders (present in 50-60% of MDD cases) 4
• Greater psychosocial impairment
• Longer episode duration
• Higher rates of substance abuse comorbidity 2

Key Diagnostic Considerations

Anxiety symptoms are the rule, not the exception, in MDD. The guidelines explicitly state that 50-60% of individuals with diagnosed depressive disorder will have comorbid anxiety disorder, with generalized anxiety being most prevalent 4. The anxiety symptoms you describe (worry, nervousness, tension) fit this pattern perfectly.

Distinguishing Features to Assess:

For MDD diagnosis, confirm:

• Duration ≥2 weeks of symptoms
• Presence of depressed mood most of the day, nearly every day
• Markedly diminished interest/pleasure in activities
• Additional symptoms: sleep disturbance, appetite/weight changes, psychomotor changes, fatigue, worthlessness/guilt, concentration difficulties, or suicidal ideation 1

For anxiety characterization, assess:

• Excessive worry about multiple topics for ≥6 months (suggests GAD)
• Restlessness, easy fatigue, concentration difficulty, irritability, muscle tension, sleep disturbance 5
• Whether anxiety preceded depression or emerged concurrently

Critical safety assessment:

• Suicidal ideation or behavior (though irritability/anger in MDD is NOT associated with increased suicidality 2)
• Risk of harm to self or others requiring emergency evaluation 4

Treatment Approach

The standard practice is to treat the depression first when comorbid anxiety is present 4. This is crucial because:

1. Treating MDD often improves comorbid anxiety symptoms
2. Most antidepressants effectively treat both conditions
3. The depression typically drives the overall clinical picture

Recommended Treatment Algorithm:

Initial intervention:

• Pharmacologic treatment with second-generation antidepressants (SSRIs, SNRIs, bupropion, mirtazapine) - no specific agent is superior; choose based on side effect profile, drug interactions, prior response, and patient preference 1, 4
• AND/OR non-pharmacologic interventions: psychotherapy, cognitive-behavioral therapy, psychoeducational therapy, or exercise 4

Important caveats:

• Antidepressants may destabilize mood or trigger mania in unrecognized bipolar disorder - screen for personal/family history of mania or hypomania
• The presence of prominent irritability/anger increases risk of bipolar II disorder in relatives 2
• If using antidepressants, warn patients about potential adverse effects and what symptoms warrant immediate contact

Follow-up Protocol:

Reassess biweekly or monthly until symptom remission 4:

• Treatment adherence and satisfaction
• Adverse effects and concerns
• Symptom reduction using standardized measures (PHQ-9 for depression, GAD-7 for anxiety) 4, 6

After 8 weeks: If inadequate response despite good compliance, modify treatment by adding/changing medication, adding psychotherapy, or referring for specialized care 4

Common Pitfalls to Avoid

1. Missing the depression diagnosis by focusing only on irritability/anger - these are markers of MORE severe MDD, not a different condition
2. Treating anxiety alone when depression is the primary driver - always address depression first in comorbid presentations
3. Overlooking bipolar disorder - irritability with mood lability may suggest bipolar spectrum, especially with family history 2
4. Inadequate dosing or duration - ensure therapeutic doses for adequate duration (typically 8+ weeks for initial trial)
5. Failing to assess suicide risk - though irritability itself doesn't increase suicidality, MDD does

The evidence strongly supports that this symptom cluster represents MDD with comorbid anxiety, where irritability and anger are severity markers rather than separate diagnostic entities 2, 3. The treatment approach should prioritize depression management while monitoring both depressive and anxiety symptoms longitudinally.